The present invention is concerned with novel cyclic sulphoximides and their preparation. These novel compounds are intermediates for a series of novel cyclic sulphoximides which show pharmaceutical activity.
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
申请人:Abbott Laboratories
公开号:EP2511264A1
公开(公告)日:2012-10-17
Disclosed are compounds of formula (II) which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
公开了抑制抗凋亡 Bcl-2 蛋白活性的式 (II) 化合物、含有该化合物的组合物以及治疗表达抗凋亡 Bcl-2 蛋白的疾病的方法。
Dhareshwar, G. P.; Chhaya, P. N.; Hosangadi, B. D., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1980, vol. 19, # 10, p. 831 - 835
作者:Dhareshwar, G. P.、Chhaya, P. N.、Hosangadi, B. D.
DOI:——
日期:——
DHARESHWAR, G. P.;CHHAYA, P. N.;HOSANGADI, B. D., INDIAN J. CHEM., 1980, 19, N 10, 831-835
作者:DHARESHWAR, G. P.、CHHAYA, P. N.、HOSANGADI, B. D.